Bedaquiline in multidrug-resistant pulmonary tuberculosis GENESIS-SEFH drug evaluation report

Bedaquiline in multidrug-resistant pulmonary tuberculosis GENESIS-SEFH drug evaluation report

Saved in:

Bibliographic Details
Main Authors:	Yolanda Borrego Izquierdo, Eduardo López Briz, Esther Márquez Saavedra
Format:	Article
Language:	English
Published:	Elsevier 2015-01-01
Series:	Farmacia Hospitalaria
Online Access:	http://www.aulamedica.es/fh/pdf/8581.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Vedolizumab in Crohn Disease genesis-sefh drug evaluation report
by: Jenifer González Chávez, et al.
Published: (2015-09-01)

EFFICIENCY OF CHEMOTHERAPY WITH BEDAQUILINE IN DRUG RESISTANT PULMONARY TUBERCULOSIS PATIENTS
by: A. M. Tikhonov, et al.
Published: (2018-03-01)

Experience of using bedaquiline in the treatment of pulmonary tuberculosis patients with multiple drug resistance
by: T. I. Morozova, et al.
Published: (2016-02-01)

Docetaxel in hormone-sensitive advanced prostate cancer; GENESIS-SEFH evaluation reporta
by: Emilio Jesús Alegre del Rey, et al.
Published: (2017-07-01)

EXPERIENCE OF USING BEDAQUILINE IN THE TREATMENT OF PULMONARY TUBERCULOSIS PATIENTS WITH MULTIPLE ANDEXTENSIVE DRUG RESISTANCE
by: N. M. Konovаlovа, et al.
Published: (2018-01-01)

Tolerability and Efficacy of Chemotherapy Containing Bedaquiline in Patients with Multiple Drug Resistant Pulmonary Tuberculosis
by: O. V. Filinyuk, et al.
Published: (2022-10-01)

Bedaquiline and linezolid regimens for multidrug-resistant tuberculosis: a systematic review and meta-analysis
by: Mahdis Cheraghi, et al.
Published: (2025-03-01)

Trastuzumab emtansine in locally advanced or metastatic HER2 positive breast cancer; GENESIS-SEFH drug evaluation report
by: Patricia Miranda Romero, et al.
Published: (2015-02-01)

EXPERIENCE OF USING BEDAQUILINE AND LINEZOLID IN THE INTEGRAL TREATMENT OF THE PULMONARY TUBERCULOSIS PATIENT WITH EXTENSIVE DRUG RESISTANCE OF M. TUBERCULOSIS
by: E. M. Zhukova, et al.
Published: (2016-10-01)

Adverse Drug Reactions in Multidrug-resistant Tuberculosis Patients on Longer Bedaquiline-based Regimen at a Tertiary Care Center in Mumbai
by: Abhishek Saini, et al.
Published: (2025-07-01)

Bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaLM) for multidrug- or rifampin-resistant tuberculosis: a systematic review
by: Denise Rossato Silva, et al.
Published: (2025-01-01)

Nintedanib in combination with docetaxel for second-line treatment of advanced non-small-cell lung cancer; GENESIS-SEFH drug evaluation report
by: María Espinosa Bosch, et al.
Published: (2016-07-01)

Clinical efficacy and computed tomography diagnostic value of bedaquiline‐containing regimens in the treatment of drug‐resistant pulmonary tuberculosis
by: Saiduo Liu, et al.
Published: (2024-09-01)

Pyrazinamide Resistance: A Major Cause of Switching Shorter to Longer Bedaquiline-based Regimens in Multidrug-resistant Tuberculosis Patients
by: Oki Nugraha Putra, et al.
Published: (2024-12-01)

Effectiveness of a bedaquiline, linezolid, clofazimine ‘core’ for multidrug-resistant TB
by: C. Zeng, et al.
Published: (2025-05-01)

Bedaquiline or delamanid improves the quality of life among patients with drug-resistant tuberculosis
by: Oki N. Putra, et al.
Published: (2025-07-01)

EXPERIENCE OF TREATMENT OF MULTIPLE DRUG RESISTANT TUBERCULOSIS PATIENTS WITH BEDAQUILINE IN AMUR REGION
by: L. Yu. Tikhonova, et al.
Published: (2018-07-01)

Eﬃcacy of using bedaquiline in treatment of tuberculosis patients with multiple and extensive drug resistance
by: A. A. Starshinova, et al.
Published: (2022-06-01)

Investigation of delamanid, bedaquiline, and linezolid resistance rates and related gene mutations in multidrug-resistant Mycobacterium tuberculosis in regional tuberculosis reference laboratories of Iran
by: Nazanin Ahmad Khosravi, et al.
Published: (2025-08-01)

New drugs in the treatment of drug-resistant tuberculosis in children. Experience with the use of delamanid in combination with bedaquiline
by: Ekaterina Sokolskaya, et al.
Published: (2024-12-01)

Bedaquiline Effect on QT Interval of Drugs-Resistant Tuberculosis Patients: Real World Data
by: I Gusti Agung Ayu Putu Sri Darmayani, et al.
Published: (2022-09-01)

Bedaquiline practice in treatment of extensively drug-resistant mycobacterium tuberculosis in children: Clinical cases
by: A. A. Akzhigitova, et al.
Published: (2022-05-01)

Use of bedaquiline in the chemotherapy regimen for multiple drug resistant tuberculosis in the HIV positive patient
by: N. D. Pirogova, et al.
Published: (2019-11-01)

Prevalence of bedaquiline resistance in patients with drug-resistant tuberculosis: a systematic review and meta-analysis
by: Xinyang Hu, et al.
Published: (2025-05-01)

The multivariate analysis of results of bedaquiline use in the therapy of MDR/XDR pulmonary tuberculosis
by: N. V. Stavitskaya, et al.
Published: (2020-08-01)

Safety and Efficacy of Bedaquiline in Drug Resistant Tuberculosis: A Hospital-based Prospective Observational Study
by: Saima Ejaz, et al.
Published: (2025-06-01)

Long-term results of chemotherapy of tuberculosis with a widespread drug-resistant pathogen using bedaquiline
by: A. Yu. Chernikov, et al.
Published: (2023-04-01)

Real World Experience of Bedaquiline-Based Anti-Tubercular Regime in Multi-Drug Resistant Tuberculosis.
by: Vikas Marwah, et al.
Published: (2025-01-01)

Experience of using two courses of bedaquiline in the adolescent with extensive drug resistant fibrous cavernous tuberculosis
by: L. V. Pаnovа, et al.
Published: (2019-08-01)

Experience of Using Bedaquiline in a Young Child with Drug Resistant Tuberculosis and Concurrent Primary Immunodeficiency
by: T. I. Danilova, et al.
Published: (2021-09-01)

Consensus SEO-SEFH of recommendations for use and compounding of ophthalmic preparations
by: Raquel Fuentes-Irigoyen, et al.
Published: (2018-03-01)

The occurrence of multidrug-resistant Mycobacterium tuberculosis from patients of pulmonary tuberculosis
by: Azhar Iqbal, et al.
Published: (2022-04-01)

Tradeoffs in Introduction Policies for the Anti-Tuberculosis Drug Bedaquiline: A Model-Based Analysis.
by: Amber Kunkel, et al.
Published: (2016-10-01)

The SEFH National Survey: An Essential Strategic Planning Resource
by: Paul W. Abramowitz, et al.
Published: (2021-01-01)

Distribution of Minimum Inhibitory Concentrations and Resistance-associated Gene Mutations in Multidrug-resistant Mycobacterium tuberculosis Strains from Southern Türkiye: Insights on Bedaquiline, Delamanid, and Linezolid
by: Huda Ahmed, et al.
Published: (2024-12-01)

Efcacy and safety of combination therapy with bedaquiline in a multimorbid HIV positive patient with multiple drug resistant tuberculosis
by: E. M. Zhukova, et al.
Published: (2022-07-01)

Immediate and Postponed Results of Short-Course Chemotherapy Regimens Containing Bedaquiline in Tuberculosis Patients with Multiple Drug Resistance
by: P. N. Golubchikov, et al.
Published: (2023-08-01)

Treatment Outcomes for Drug-Resistant Tuberculosis Patients on Bedaquiline-Based Regimens in a Mostly Rural South Africa
by: Rukasha I, et al.
Published: (2025-04-01)

Cost-effectiveness of bedaquiline, pretomanid and linezolid for treatment of extensively drug-resistant tuberculosis in South Africa, Georgia and the Philippines
by: Francesca Conradie, et al.
Published: (2021-12-01)

Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy
by: Luigi R. Codecasa, et al.
Published: (2017-01-01)